News

Xavier said that patients are often reluctant to quit smoking because they are fearful that they will gain weight. By adding ...
New review confirms psychiatric safety of commonly used glucagon-like peptide 1 receptor agonists among patients without ...
Treating nicotine addiction with glucagon-like peptide 1 receptor agonists is associated with less weight gain compared with ...
David Kessler has lost more than 60 pounds on weight-loss drugs and believes they can change the trajectory of chronic ...
The recent decision by some US states to cover glucagon-like peptide-1 (GLP-1) agonists for obesity treatment marks a shift ...
Cigna subsidiary Evernorth Health Services will authorize prior authorizations for GLP-1 weight-loss drugs under a new ...
After the the FDA declared an end to the shortage of GLP-1 medications, compounded versions of the drug must be out of the market by Thursday.
Menopausal hormone treatment (MHT) might indirectly help with weight loss by improving sleep and redistributing abdominal fat ...
Despite the popularity of semaglutide drugs like Ozempic and Wegovy for weight loss, surveys suggest that most people still ...
KANSAS CITY, MISSOURI, US — Already on the path toward healthier, nutrient-dense products, the increasing popularity of GLP-1 ...
GLP-1 receptor agonists are associated with improvements in restrained eating, emotional eating behavior, QOL.